Skip to content
Live funding
↑Microbiotica €42.7M Series C round led by British Business Bank ↑Goodweek €10.7M funding round led by Adara Ventures ↑Qilimanjaro Quantum Tech €19.6M raises a Series A round ↑Ambio €5.1M Seed round led by Lifeline Ventures ↑Duvo €28.5M Series A round led by Balderton Capital ↑Salience Labs €111.4M Series B round led by Bullhound Capital ↑Wavo €10M funding round led by Eurazeo ↑Cofrai €2.6M funding round led by DFF Ventures ↑Undecimal Bio €16M Seed round led by 4BIO Capital ↑Obsero €1M Seed round led by SFC Capital ↑ParkMundo €2.3M Seed round led by Rabobank ↑Ubitium €12.5M Seed round led by Ibex Investors ↑Alchera Technologies €3.2M Seed round led by Maven Capital Partners ↑Sainaptic €1.2M funding round led by Brighteye Ventures ↑reebuild €3M Seed round led by Rise PropTech ↑Causa Prima €17.9M Seed round led by Base10 Partners ↑Affinity Labs €1.8M Pre-seed round led by Antler ↑Epyr €15M Series A round led by SlateVC ↑CarbonFarm €7M Series A round led by Colam Impact ↑CMR Surgical €358.1M funding round led by Stryker
Sesame Summit 2027
Sesamers
Point Nine Capital

Point Nine Capital

● Actively deploying Berlin, Germany · Founded 2011

Investment thesis

Point Nine is a pre-seed and seed investor in B2B software, SaaS and AI, based in Europe and investing globally. It is structured as a small equal partnership of four partners, each working closely with six to eight companies, and invests $1M to $10M per company. The firm is thesis-driven and is extending its focus to AI for the digital, physical and biological world.

Past investments

Company Round Date Round size
Procuros Hamburg, Germany Series A Oct 2026 €20M
Wikifarmer Athens, Greece - Mar 2026 €7.1M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.